[EN] FAK AND FLT3 INHIBITORS<br/>[FR] INHIBITEURS DE FAK ET FLT3
申请人:CANCER THERAPEUTICS CRC PTY LTD
公开号:WO2014027199A1
公开(公告)日:2014-02-20
The use of a compound of the formula (I): (Formula (I)) in the preparation of a medicament for treating Acute Myeloid Leukemia or a disease ameliorated by the inhibition of Flt3, or Flt3 and FAK.
A compound of the formula (I):
where R
1
or R
2
is a cyclc amine group and R
5
is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.
A compound of the formula (I):
where R1 or R2 is a cyclc amine group and R5 is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.
A compound of the formula (I): where R1 or R2 is a cycle amine group and R5 is an aromatic group with a carbonyl containing substituent for use as a FAK inhibitor.